ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
ROTIGOTINUM
Active substance (INN) · ATC N04BC09 · 10 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
| Code | Protocol | Status | Role | Sublist | GP |
|---|---|---|---|---|---|
| N0026G | ROTIGOTINUM | In force | medicine of the protocol | C1-G12 | YES |
2
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
| Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|
| KINPARLEV 1 mg/24 h | PLASTURE TRANSDERMIC | 1mg/24h | ORION CORPORATION - FINLANDA | N04BC09 | PRF |
| KINPARLEV 2 mg/24 h | PLASTURE TRANSDERMIC | 2mg/24h | ORION CORPORATION - FINLANDA | N04BC09 | PRF |
| KINPARLEV 3 mg/24 h | PLASTURE TRANSDERMIC | 3mg/24h | ORION CORPORATION - FINLANDA | N04BC09 | PRF |
| KINPARLEV 4 mg/24 h | PLASTURE TRANSDERMIC | 4mg/24h | ORION CORPORATION - FINLANDA | N04BC09 | PRF |
| KINPARLEV 6 mg/24 h | PLASTURE TRANSDERMIC | 6mg/24h | ORION CORPORATION - FINLANDA | N04BC09 | PRF |
| KINPARLEV 8 mg/24 h | PLASTURE TRANSDERMIC | 8mg/24h | ORION CORPORATION - FINLANDA | N04BC09 | PRF |
| NEUPRO 2 mg/24h | PLASTURE TRANSDERMIC | 2mg/24h | UCB PHARMA S.A. - BELGIA | N04BC09 | PRF |
| NEUPRO 4 mg/24h | PLASTURE TRANSDERMIC | 4mg/24h | UCB PHARMA S.A. - BELGIA | N04BC09 | PRF |
| NEUPRO 6 mg/24h | PLASTURE TRANSDERMIC | 6mg/24h | UCB PHARMA S.A. - BELGIA | N04BC09 | PRF |
| NEUPRO 8 mg/24h | PLASTURE TRANSDERMIC | 8mg/24h | UCB PHARMA S.A. - BELGIA | N04BC09 | PRF |